Vistagen Therapeutics, Inc. (VTGN)
NASDAQ: VTGN · Real-Time Price · USD
2.500
+0.250 (11.11%)
At close: Dec 20, 2024, 4:00 PM
2.600
+0.100 (4.00%)
After-hours: Dec 20, 2024, 7:59 PM EST

Vistagen Therapeutics Market Cap

Vistagen Therapeutics has a market cap or net worth of $69.61 million as of December 20, 2024. Its market cap has decreased by -47.11% in one year.

Market Cap
69.61M
Enterprise Value
-26.18M
1-Year Change
-47.11%
Ranking
Category
Stock Price
$2.50

Market Cap Chart

Since May 11, 2016, Vistagen Therapeutics's market cap has increased from $9.30M to $69.61M, an increase of 648.48%. That is a compound annual growth rate of 26.32%.

History

DateMarket Cap% Change
Dec 20, 202469.60M-49.89%
Dec 29, 2023138.90M552.11%
Dec 30, 202221.30M-94.53%
Dec 31, 2021389.40M171.17%
Dec 31, 2020143.60M381.88%
Dec 31, 201929.80M-36.05%
Dec 31, 201846.60M258.46%
Dec 29, 201713.00M-58.47%
Dec 30, 201631.30M236.56%
View and export this data all the way back to 2016. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition